City National Bank’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-9,739
Closed -$3.88M 889
2015
Q2
$3.88M Sell
9,739
-23,588
-71% -$10M 0.03% 299
2015
Q1
$16.4M Buy
33,327
+7,994
+32% +$3.1M 0.14% 161
2014
Q4
$9.06M Buy
25,333
+2,358
+10% +$702K 0.08% 221
2014
Q3
$4.43M Buy
22,975
+1,135
+5% +$250K 0.04% 276
2014
Q2
$5.22M Buy
21,840
+11,813
+118% +$2.4M 0.05% 260
2014
Q1
$2.56M Buy
10,027
+3,082
+44% +$942K 0.04% 276
2013
Q4
$1.38M Buy
6,945
+3,123
+82% +$555K 0.02% 365
2013
Q3
$646K Sell
3,822
-123
-3% -$19.8K 0.01% 470
2013
Q2
$700K Buy
+3,945
New +$559K 0.01% 467

Other funds holding LUMO

City National Bank's LUMO Position: Q3 2015 in Review

City National Bank sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2015, closing a stake of 9,739 shares — an estimated $3.88M sold.

City National Bank first reported a position in LUMO in Q2 2013 and held it in 9 quarters. The position peaked at $16.4M in Q1 2015. 152 funds tracked by Wall St. Rank hold LUMO as of Q3 2015.

  • City National Bank reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • City National Bank sold 9,739 Lumos Pharma, Inc. Common Stock shares in Q3 2015, an estimated $3.88M.
  • City National Bank first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 9 quarters.
  • City National Bank's Lumos Pharma, Inc. Common Stock position peaked at $16.4M in Q1 2015.
  • 152 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.